Pulses of growth hormone (GH) release in acromegaly may arise from hypothalamic regulation or from random events intrinsic to adenomatous tissue. To distinguish between these possibilities, serum GH concentrations were measured at 5-min intervals for 24 h in acromegalic men and women with active (n = 19) and inactive (n = 9) disease and in normal young adults in the fed (n = 20) and fasted (n = 16) states. Daily GH secretion rates, calculated by deconvolution analysis, were greater in patients with active acromegaly than in fed (P < 0.05) but not fasted normal subjects. Significant basal (nonpulsatile) GH secretion was present in virtually all active acromegalics but not those in remission or in fed and fasted normal subjects. A recently introduced scale-and model-independent statistic, approximate entropy (ApEn), was used to test for regularity (orderliness) in the GH data. All but one acromegalic had ApEn values greater than the absolute range in normal subjects, indicating reduced orderliness of GH release; ApEn distinguished acromegalic from normal GH secretion (fed, P < 1012; fasted, P < 10-') with high sensitivity (95%) and specificity (100%).
Introduction
We and others have reported that increased pulse frequency and interpulse concentrations characterize growth hormone (GH)' release in acromegaly as determined by several objective pulsedetection algorithms (1, 2) . However, little is known about the nature of the secretory events at the level of the anterior pituitary gland that give rise to these changes in serum GH concentrations. Secretion cannot be inferred readily from the serum GH concentrations, because of the confounding influence of ongoing metabolic clearance, which has been reported to be normal (3) (4) (5) (6) , increased (7, 8) or decreased (6, 9, 10) in acromegaly. Furthermore, whether episodes of GH secretion arise from normal hypothalamic regulation or from random events intrinsic to adenomatous tissue is unknown. Pulsatile GH release persists during continuous infusions of GH releasing hormone (GHRH) (11) , octreotide (a long-acting somatostatin analogue) treatment (12, 13) , during pregnancy when insulin-like growth factor-I (IGF-I) levels are increased (14) , and during fasting when IGF-I levels are decreased (15) . These observations have been interpreted by some groups as evidence that hypothalamic regulation of GH secretion persists in acromegaly, with perhaps decreased negative feedback by IGF-I (11, 12, 14, 15) . However, high frequency pulsatile release of GH has also been observed in vitro from perifused primate hemipituitaries (16) . Thus, episodic GH release in vivo by somatotroph adenomas may also reflect secretory events that are independent of hypothalamic regulation.
We hypothesized that GH secretion in acromegaly is primarily autonomous with irregular secretory activity superimposed upon enhanced basal secretion. In contrast, normal GH secretion is characterized by minimal basal secretion and highly regulated pulses of GH secretion. To evaluate these hypotheses, we used several recently developed analytical and mathematical methods to compare objectively acromegalic and normal episodic GH secretion. To evaluate basal secretion we used high, intermediate, and low literature values of the GH t1,2 in conjunction with a waveform-independent deconvolution method that requires no assumptions about the nature or time-course of underlying hormone secretory events (17) . Regularity in the GH concentration-time series was quantified with a recently introduced statistic termed approximate entropy (ApEn), which calculates the logarithmic likelihood that patterns that are similar remain similar on the next incremental comparison (18) . ApEn is a modelindependent (no assumptions about periodicity or waveforms) and scale-independent (unaffected by differences in mean values) statistic, which has been shown to discern differences in Disorderly Growth Hormone Secretion in Acromegaly underlying episodic behavior that may not be detected by pulse detection algorithms (19) . The presence of underlying periodic rhythms was also assessed by classical Fourier time series analysis (20) . Physiologically enhanced (e.g., by fasting) GH secretion in normal subjects was compared with that of acromegalic patients to test the possibility that observed differences between normal and acromegalic GH release were the result of undetectable GH concentrations throughout much of the day in fed normal subjects (21, 22) . We report that episodic GH release in acromegaly can be distinguished objectively from physiological GH secretion by: (a) enhanced basal (interpulse) GH secretion; (b) increased irregularity (disorderliness) in the patterns of GH release; and (c) a relative damping of underlying periodic rhythms.
Methods
Subjects and study design. The studies were approved by the Human Investigation and General Clinical Research Center Advisory Committees of the University of Virginia. All patients and normal volunteers gave written informed consent. 19 patients with active acromegaly (9 men, 10 women; ages 24-64) were studied; five patients had previously been treated with transsphenoidal surgery and/or radiation therapy but had residual active disease. Previous medical treatments included bromocriptine in four patients (discontinued 2-6 wk before study) and octreotide in two patients (discontinued 4-18 mo before study). The diagnosis was based on the failure of serum GH concentrations to decrease to <1 tg/l after ingestion of 100 g glucose and an elevated serum IGF-I concentration. Nine acromegalic patients (three men, six women; ages were studied during biochemical remission defined by a post-oral glucose GH nadir of < 1 sg/l; eight patients had been treated with transsphenoidal surgery and/or radiation therapy and one received bromocriptine therapy. All nine patients considered to be in remission had serum IGF-I concentrations within the normal range of young adults. Two of these patients had serum IGF-I levels which were slightly higher than expected for older adults (1, 23 (17) . Furthermore, the GH t1, and the time-dependent shape of underlying GH secretory events in acromegaly is unknown. To circumvent these problems, we used a waveform-independent deconvolution method, which calculates hormone secretion rates at each time point given an estimated hormone t1,2 and its associated variance, without making any assumptions about the nature of underlying hormone secretory events (17) . For normal subjects, a previously determined estimate of the two-component endogenous GH tin was used (mean±SEM): (a) distribution phase (a), 3 .5±0.7 min; (b) elimination phase (), 20 (17) . The more stringent Z score (3.5) to define significant first derivatives was chosen to constrain the false positive peak detection rate to < 5%, based on preliminary validation studies using simulated GH pulse series generated by a multiple parameter convolution integral model (28) . This analysis indicated that false positive peaks were detected more frequently in data with elevated baselines, as occurs with acromegalic data. Basal (nonpulsatile) GH secretion was defined to be present when mean lowest interpulse (nadir) secretion rates were significantly greater than zero (Z score > 1.645, P < 0.05). Calculated GH secretion rates and their statistical confidence intervals are expressed as jg GH secreted per liter of distribution volume (Lv) per min (Isg L-' min-'). Daily (24-h) GH production rates were estimated by multiplying the mean GH secretion rate by 1440 min.
Approximate entropy statistic (ApEn). ApEn is a model-independent statistic for assessing regularity of time-series data (18) . It assigns a single nonnegative number to a time series with larger values corresponding to greater apparent process randomness. ApEn measures the logarithmic likelihood that runs of patterns that are similar remain similar on next incremental comparisons. The calculation of ApEn is given in Appendix A. Two input parameters, m and r, must be fixed to compute ApEn. For this study, we calculated two sets of ApEn values for each data set: (a) m = 1, r = 20% of the average SD of the GH time-series; (b) m = 2, and r = 20% of the average SD of the GH time-series. Previous studies that included both theoretical analysis and clinical applications have demonstrated that these input parameters will produce good statistical validity for ApEn for time series of upwards of 100 data points (18, 19, (29) (30) (31) .
ApEn has been demonstrated to be very stable to small changes in noise characteristics, and infrequent and significant data artifacts. It accounts for a variety of dominant and subordinate patterns in data; notably, it will detect (be affected by) changes in underlying episodic behavior that are not reflected in changes in peak occurrences or amplitudes (19) . Additionally, ApEn provides a direct barometer of feedback system change in many coupled systems.
In choosing the r input parameter in ApEn as a fixed percentage of each data set's SD, we normalize each epoch by its overall SD. We call this normalized regularity (30) . We thus decorrelate the SD and the present quantification of regularity, ApEn, in that ApEn as specified above is scale invariant-constant signal scale enlargement would produce the identical ApEn value to the base signal ApEn value.
Finally, ApEn is a relative, not absolute measure of process regularity, and can show significant variation with changing m or r input parameters, and changing noise characteristics (18, 19, 29, 31) . Since ApEn will generally increase with increasing process noise (and increasing intra-assay variation), it is important to compare data sets with similar assay CVs, as we do here.
Coefficient of variation of incremental change [CV( AX, I)]. In a
time-series of data X1, X2, . . . Xn, the incremental change AX*, defined as Xi,, -Xi, is a standard quantification of short-term variation. We study the coefficient of variation (SD/mean) of all the AXi in a data set as an index of the constancy of incremental change in the time series. Data with a relatively steady rate of change will have a small CV (I AXi I) whereas data with much of the overall statistical variation occurring in brief bursts will have a large CV (I AXi I). Since superimposed noise tends to be relatively constant in magnitude, a large CV (I AX I) would rarely be due to noise alone, and would typically rather appear to mark abrupt input/output changes, as opposed to steady flow.
We calculated CV (I AXi I) to test the hypothesis that GH secretion in acromegaly has a more nearly constant incremental change over time compared to normal GH secretion, which is characterized by more prominent and distinct bursts of secretory activity. CV (I AXj I) is scale invariant in the sense stated above, so this comparison is not affected by the differences in mean GH concentrations between acromegalic and normal subjects.
Fourier series analysis. Normal GH secretion is characterized by a nyctohemeral rhythm (GH concentrations highest at night) and higher frequency ultradian rhythms. To test the hypothesis that underlying periodicity in GH secretion is damped in acromegaly, each GH concentration-time series was analyzed as a Fourier expansion, which yielded a function that traverses all the data points as an exact linear composite of distinct sine and cosine functions with (n -1)/2 periodicities. The Fourier analysis was truncated to exclude very high-order terms that correspond to experimental noise (20) . This optimal order of fit (e.g., number of harmonics) was determined by two independent statistical methods: (a) the runs test for randomness of residuals (32); and (b) the Akaike information content to monitor overparameterization (33 Results 24-h profiles of serum GH concentrations and GH secretion rates. Fig. 1 depicts serum GH concentrations measured in blood obtained at 5-min intervals for 24 h from two patients with active acromegaly and two patients with acromegaly in biochemical remission after transsphenoidal surgery. Fig. 2 illustrates 24-h GH profiles from two normal subjects in the fed state and on the fifth day of a water-only fast to enhance GH secretion physiologically. In Fig. 3 , GH sample secretion rates corresponding to the males shown in Fig. 1 and 2 are shown. Visual inspection of these typical profiles suggests that in normal subjects GH secretion occurs in distinct bursts with intervening periods of relative secretory quiescence. With fasting, serum GH concentrations become continuously elevated but the pattern of prominent bursts of secretory activity with interpeak nadir secretion rates approaching zero is maintained. In acromegaly, GH concentrations are also continuously elevated but the bursts of GH release appear to be less prominent in comparison with the elevated baseline. As shown in Fig. 3 , the distribution of sample GH secretion rates is markedly different in acromegaly. In physiological GH secretion, the distribution is skewed with the modal value near zero (corresponding to the assay sensitivity). In contrast, in acromegaly the distribution of secretion rates is more nearly symmetric with the mode significantly above zero, corresponding to the increased baseline. After successful transsphenoidal surgery the 24-h profiles resemble those of normal subjects with baseline GH concentrations frequently approaching assay sensitivity.
Estimates of24-h GHproduction rates. Fig. 4 illustrates the 24-h GH production rates estimated by a waveform-independent deconvolution algorithm for the four groups of patients: (a) acromegalic patients with active disease; (b) acromegalic patients in biochemical remission; (c) normal subjects in the fed state; and (d) normal subjects on day 5 of a fast (enhanced GH secretion). As described above, estimates of 24-h GH production rates for the acromegalic patients were derived using low, Estimates of basal GH secretion rates. Fig. 5 depicts estimates of basal (nonpulsatile) GH secretion rates derived from waveform-independent deconvolution analysis with the three estimates of /. Basal GH secretion was defined to be present when mean lowest interpulse (nadir) secretion rates were significantly greater than zero (Z score > 1.645, P < 0.05). All fed normal subjects had basal GH secretion rates that were statistically indistinguishable from zero. With one exception, basal GH secretion was also not significant in fasted normal subjects. In contrast, significant basal secretion was present in 18/19 acromegalic patients with the low estimate, and in 15/ which were significantly lower than those of normal subjects in either the fed (1.73±0.61) or fasted (1.84±0.86) states (P < 0.001). This indicates that acromegalics have relatively constant changes in GH concentrations across successive measurements. In contrast, the large bursts of GH secretion in normal subjects produce higher values of CV (I AXi I (P < 0.05), but not significantly different from the fasted normal subjects. Another interesting observation of unclear significance is that fewer harmonics were required to fit GH data in acromegalics (16±1.8) compared to fed (42±2.9) and fasted (33±0.9) normal subjects (P < 0.05). Patients in remission required an intermediate number of harmonics (28±1.7).
Discussion
In this study we demonstrate that GH secretion in acromegaly is distinguished from normal pulsatile GH secretion by: (a) enhanced basal (nonpulsatile) secretion; and (b) higher approximate entropy (ApEn) values that suggest a disordered mode of secretion. These characteristics also reliably separate acromegaly from physiologically enhanced GH secretion during fasting. In contrast, 24-h mean serum GH concentrations and daily GH production rates in some patients with acromegaly overlapped with values of both fed and fasted normal subjects. In addition, GH release in acromegaly was characterized by: (a) relative damping of underlying regularly periodic rhythms; and (b) more nearly constant incremental changes from sample to sample.
Previous studies of GH release in acromegaly were limited to descriptions of the patterns of serum GH concentrations using conventional pulse detection algorithms; more statistically significant pulses of GH release were identified in acromegalics compared to normal subjects (1, 2) . However, it has remained unclear whether this finding represented hypothalamic control of GH secretion (i.e., increased episodic secretion of GHRH and/or more somatostatin withdrawal) or secretory events intrinsic to the adenomatous tissue. Furthermore, since serum GH concentrations become undetectable in most conventional immunoassays for portions of the day in normal subjects (21), the relatively higher GH pulse frequency in acromegalic versus normal subjects may be related to underestimation of the GH pulse frequency in the latter (1, 13). In addition, previous studies did not address, in an analytical manner, the possibility that "pulses" detected by pulse detection algorithms may arise from distinctly different secretory mechanisms in different types of patients. The higher ApEn scores in our acromegalic patients indicate that in this disease GH is secreted in a distinctly more irregular manner than in normal subjects. Physiological enhancement of GH secretion, as occurs with fasting, likely results from decreased somatostatin and/or increased GHRH secretion (22, 34) , as well as reduced negative feedback by IGF-I (35) . Since our fasted subjects had ApEn scores that were significantly lower than those of acromegalic patients, this new finding suggests that GH secretion in acromegaly does not arise from these normal hypothalamic control mechanisms. A plausible interpretation of these observations would be that "pulses" observed in serum GH concentration profiles of acromegalic patients arise primarily from irregular bursts of secretory activity by adenomatous tissue. In support of this hypothesis, normal perifused monkey anterior hemipituitaries secrete GH in a spontaneously pulsatile manner (16) . This does not exclude some measure of hypothalamic control, since GHRH can increase, and somatostatin can decrease, serum GH concentrations in acromegalics (11) (12) (13) 36) . However, elevated blood concentrations of GH and IGF-I would be expected to result in decreased GHRH and enhanced somatostatin secretion via normal feedback to the hypothalamus. Thus, it is likely that the usual ordered control of GH secretion by GHRH and somatostatin is greatly diminished in active acromegaly. Since acromegalics in remission had ApEn scores that were intermediate between those of acromegalics with active disease and normal fed or fasted subjects, it is possible that a component of abnormal or disorderly hypothalamic control of GH secretion exists in acromegaly.
Previous investigations have also reported that serum GH concentrations in acromegaly are elevated continuously throughout the 24-h period ( 1, 2, 11-13) . Theoretically, this could result from: (a) enhanced basal (interpulse) secretion; (b) a prolonged GH t1,2 (decreased clearance); or (c) very frequent and/or high amplitude GH secretory bursts that deliver more GH than can be removed between successive events by the usual rate of metabolic clearance. The last model has been proposed to account for the continuously elevated serum GH concentrations in fasting normal subjects (22) . Here, we report that statistically significant basal GH secretion is demonstrable in virtually all acromegalic patients and is absent in almost all fed and fasted normal subjects. The use of low, intermediate or high literature estimates of the GH elimination tj,2 in our deconvolution analysis produced qualitatively the same results. Thus, significant basal GH secretion, estimated from serum GH concentrations measured with a conventional GH IRMA, is highly suggestive of acromegaly regardless of which t1,2 estimate is used. In this study, undetectable amounts of GH (below the sensitivity of the IRMA) were present in 46±7.6% and 17±6.8% of blood samples withdrawn over 24-h in the fed men and women, respectively; this makes it difficult to accurately estimate the amount and nature of low basal GH secretion in normal subjects. In the fasted state, GH was measurable in 98-99% of samples in both men and women. Recently, GH assays with enhanced sensitivity have become available that enable serum GH concentrations to be measured in all samples obtained throughout a 24-h period. Preliminary evidence, obtained with a GH chemiluminescence assay with a sensitivity of 0.005 jugfl and deconvolution analysis, indicates that very low levels of basal GH secretion exist in normal subjects (37) . Thus, it is likely that basal GH secretion is present in normal subjects but contributes very little (< 5% in young adults) to the overall 24-h GH production rate (37) . In contrast, basal GH secretion is markedly enhanced in acromegaly and accounts for a large portion of the 24-h GH production rate. As estimated in our study, basal secretion accounted for 69, 45, and 38% of 24- (40) (41) (42) (43) (44) (45) . The mutant G. is unable to hydrolyze GTP, which results in constitutive activation of adenylate cyclase, high intracellular cAMP concentrations, and high in vitro GH secretion rates that are not significantly augmented by GHRH, since cAMP is the pathway that mediates GHRH action (41, 42, 46) . Decreased methylation of the GH gene may result in increased GH gene expression in somatotroph adenomas (40, 47) . However, a role for GHRH as a tumor promoter cannot be excluded, particularly since pituitary adenomas occur in mice transgenic for GHRH (48) and in patients with excessive central GHRH hypersecretion on a congenital basis (49) or in association with hypothalamic gangliocytomas (50) .
In vitro studies of human somatotroph adenoma cells support our model of disordered, semi-autonomous GH secretion. Under identical cell culture conditions, adenoma cells secrete less GH in response to GHRH than normal rat pituitary cells (51) . Although GHRH increases the amount of GH secreted per cell in both normal and adenomatous pituitary cells, the percentage of cells secreting GH is increased only in normal somatotrophs (52, 53) . In normal rat somatotrophs the frequency and amplitude of intracellular calcium ion oscillations correlates with the amount of GH secreted spontaneously per cell (53) . In contrast, high levels of basal GH secretion occur in human somatotroph adenomas with only 0-5% of cells exhibiting spontaneous calcium oscillations (54) . This loss of normal stimulus-secretion coupling in adenoma cells may produce a less ordered pattern of secretion, which we are detecting in our analysis of serial serum GH concentrations by higher ApEn scores.
Although a variety of clinical studies of GH release in acromegaly have been individually interpreted to suggest that GH pulses in acromegaly arise from hypothalamic regulation, we suggest that alternatively these studies can support our hypothesis that these pulses likely are of pituitary origin. For example, in acromegaly, GH pulse frequency is unaffected by continuous infusions of GHRH (11) or the somatostatin analogue, octreotide (12, 13) . Furthermore, changes in plasma IGF-I concentrations, whether increases during pregnancy or decreases during fasting, do not alter the GH pulse frequency (14, 15) . Thus, although the amplitude of GH pulses may be regulated in part by these factors, the origin of the pulses is likely intrinsic to the pituitary adenoma and less susceptible to extrinsic regulation. Administration of a GHRH antagonist to acromegalic patients may provide another means to test this hypothesis, although in normal subjects such treatment decreased GH pulse amplitudes but did not change pulse frequency (55) . Variable GH responses to GHRH have been reported in acromegalic patients (36) . This may reflect in part the fact that gsp positive tumors are less responsive to GHRH (44) . However, the presence or absence of the gsp mutation does not appear to alter the pattern of GH release consistently in any other significant way. Both lower (40, 43) The possible clinical utility of these analytical methods in the diagnosis of either early acromegaly or recurrent acromegaly after initially successful transsphenoidal surgery will require further study. Significant basal GH secretion was not detected in any of our acromegalic patients in clinical and biochemical remission. Although our controls included fasting subjects with uniformly detectable serum GH concentrations, these analyses will need to be repeated with more sensitive GH assays to allow a proper comparison with low levels of basal GH release in normal fed subjects. It is unlikely that the use of more sensitive assays will change our conclusions with ApEn since highly significant differences were found between fasting normal subjects and acromegalic patients. Our patients in remission had ApEn scores that were intermediate between those of patients with active acromegaly and normal fed subjects but significantly different from both groups. Does this indicate residual pituitary tumor tissue, which is sufficient to alter the pattern of GH release but not increase IGF-I levels? Or does this reflect an element of altered hypothalamic regulation, which is unmasked by the removal of pituitary tumor tissue? It is possible that deconvolution analysis of basal GH secretion and analysis of the regularity of GH release by ApEn will be useful in situations where early acromegaly is otherwise difficult to distinguish from normal GH release. The scale-independence of ApEn may make this statistic particularly useful in mild acromegaly (early disease and residual or recurrent disease after transsphenoidal surgery) when mean serum GH concentrations are not clearly elevated beyond the range observed in normal subjects.
We conclude that GH secretion in acromegaly is highly irregular and disorderly with accompanying significant basal secretion. We hypothesize that somatotroph adenomas secrete GH at high constitutive rates in a random, episodic manner with decreased control by the normal orderly release of GHRH and somatostatin by the hypothalamus. Our results suggest that GH When m = 2, as we employ, we interpret ApEn as a measure of the difference between the probability that runs of value of length 2 will recur within tolerance r and the probability that runs of length 3 will recur (to the same tolerance). A high degree of regularity in the data would imply that a given run of length 2 would often continue with nearly the same third value, producing a low value of ApEn. Appendix B Results are mean ± SD; P values based on two-sided t test, unknown, unequal variances.
